Guides

Kaposi’s Sarcoma and HIV

Kaposi’s sarcoma and HIV
Guides

Kaposi’s Sarcoma and HIV

References UK clinical guidance from the NHS, the British HIV Association (BHIVA), and the British Association for Sexual Health and HIV (BASHH). Last updated: April 2026.

Kaposi’s sarcoma (KS) is a cancer that causes abnormal tissue to grow under the skin, in the lining of the mouth, nose or throat, or in other organs. It is caused by human herpesvirus 8 (HHV-8) and is strongly associated with HIV, particularly in people with low CD4 counts. KS was one of the first conditions recognised during the AIDS epidemic and remains an AIDS-defining illness.

With effective HIV treatment, KS has become much less common in the UK.

Order a discreet home HIV test

What Causes KS?

KS is caused by HHV-8 (also called Kaposi sarcoma-associated herpesvirus or KSHV). Most people with HHV-8 never develop KS, but the virus can cause cancer when the immune system is weakened by HIV. KS almost always occurs when CD4 counts are low.

Symptoms

  • Dark red, purple or brown patches or nodules on the skin
  • Lesions can appear anywhere but are common on legs, face and genitals
  • Lesions in the mouth (palate, gums)
  • Swelling in the legs (lymphoedema)
  • If internal: cough, breathlessness, abdominal pain, bleeding
LocationSymptoms
SkinPainless dark lesions, may be flat or raised
MouthPurple patches on palate or gums
LungsBreathlessness, cough
GutBleeding, pain, diarrhoea
Lymph nodesSwelling, especially legs

Diagnosis

KS is diagnosed by biopsy of a skin lesion. If internal KS is suspected, imaging (CT scan) and endoscopy may be needed. HHV-8 testing can confirm the underlying viral cause.

Treatment

Starting or optimising ART

The most important treatment for HIV-related KS is effective antiretroviral therapy. Restoring the immune system often causes KS lesions to shrink or disappear entirely. Many cases of mild KS resolve with ART alone.

Chemotherapy

For more extensive or aggressive KS, chemotherapy is used alongside ART. Liposomal doxorubicin is the most common first-line option. Paclitaxel is used for relapsed disease.

Local treatments

For small, cosmetically bothersome skin lesions: radiotherapy, cryotherapy or surgical excision.

Prevention

  • Start ART promptly after HIV diagnosis
  • Maintain an undetectable viral load
  • Report any new skin lesions or mouth changes to your HIV team

Read more: Cancer and HIV | Lymphoma and HIV | What is HIV?

Frequently Asked Questions

Can KS come back after treatment?

Yes, particularly if HIV is not well controlled. Staying on effective ART with an undetectable viral load is the best protection against recurrence.

Is KS contagious?

KS itself is not contagious, but HHV-8 can be transmitted through saliva. Most people who acquire HHV-8 never develop KS.

Does KS only affect people with HIV?

No. Other forms of KS exist in people without HIV, but HIV-related KS is the most common and aggressive form.

Sources

Have questions? Get tested from home.

Confidential, accurate, and rapid results you can trust.

Order a Test Kit